APT Medical
APT Medical (688617.SH) is a Chinese medical device company developing cardiac electrophysiology and vascular interventional devices, including a proprietary magnetic-electric fusion 3D mapping platform, RF and pulsed field ablation catheters, and a full coronary pathway product portfolio, sold to hospitals in China and 88+ international markets.
- Company typePublic
- Founded2002
- HeadquartersShenzhen, China
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What APT Medical does
APT Medical (深圳惠泰医疗器械股份有限公司, Shanghai STAR Market ticker 688617.SH) is a Chinese high-tech medical device company founded in 2002 and headquartered in Shenzhen, with manufacturing operations in Xiangtan (Hunan) and a Shanghai Xihongqiao headquarters project under construction. The company specializes in cardiac electrophysiology and vascular interventional devices, organized into four product verticals: electrophysiology products (3D mapping systems, RF and pulsed field ablation catheters, mapping catheters, transseptal access systems), coronary pathway products (diagnostic and therapeutic guidewires, microcatheters, PTCA balloons, guide extension catheters, thrombectomy catheters), peripheral vascular products (TIPS instruments, peripheral balloons, PVA embolization microspheres), and OEM/ODM services for catheters, tubing, sheaths, guidewires, and nitinol components. Its flagship platform, the HT Viewer™ (HT-9000), is described as the world's first 'three-in-one' magnetic-electric fusion 3D cardiac electrophysiology mapping system integrating a 3D mapping system, 128-channel multi-channel recorder, and cardiac stimulator with sub-millimeter positioning accuracy; this anchors an expanding PFA ecosystem (AForcePlus™, Pulstamper™, PFG-micro1 generator) launched domestically in 2025.
Revenue is generated primarily through B2B sales of proprietary medical devices and consumables to hospitals, with capital equipment (3D mapping systems, ablation generators) creating a recurring consumables tail as procedure volumes grow. The go-to-market combines direct sales to over 500 electrophysiology hospitals and 1,600+ vascular intervention hospitals in China with international distribution reaching 88+ countries, supported by distributor partnerships (e.g., KLN in Hong Kong) and physician training programs (CDQI, Jingxin Classroom, complex PCI camps at Fudan Zhongshan Hospital). Reported 2025 revenue reached approximately CNY 3.69B, implying a 44% multi-year CAGR, with the company designated as a national-level specialized, refined, and innovative 'Little Giant' enterprise by China's MIIT. As of January 2026, Mindray Medical disclosed APT Medical as a strategic acquisition to expand its cardiovascular intervention footprint, signaling a major near-term ownership transition; APT Medical's wholly-owned operating subsidiaries are Shanghai Hongtong Industrial (R&D/manufacturing for HT-9000) and Hunan APT Medical Devices (interventional device production).
APT Medical firmographics
Firmographics- Name
- APT Medical
- Legal name
- 深圳惠泰医疗器械股份有限公司
- Website
- https://aptmed.com.cn
- Company type
- Public
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- APT Medical (688617.SH) is a Chinese medical device company developing cardiac electrophysiology and vascular interventional devices, including a proprietary magnetic-electric fusion 3D mapping platform, RF and pulsed field ablation catheters, and a full coronary pathway product portfolio, sold to hospitals in China and 88+ international markets.
- Ownership category
- akta.pro rank
APT Medical industry classification
Industry- Product category
- Cardiovascular Interventional Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Electrophysiology Mapping & Ablation Systems (HLAHAFAD)
- akta.pro secondary industries
- Interventional Cardiology (PCI/Structural Heart) (HLAKABAB), Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories) (HLAHAKAE)
Keywords
Where APT Medical is headquartered
LocationHeadquarters
- HQ city
- Shenzhen
- HQ country
- China
- HQ region
- Asia
Offices3 records
Markets served
APT Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device and Consumable Sales: APT Medical generates revenue through the sale of proprietary electrophysiology and vascular intervention medical devices and consumables. Products include ablation catheters, mapping catheters, guidewires, microcatheters, balloon catheters, vascular sheaths, and capital equipment (3D mapping systems, ablation generators). Revenue is primarily one-time capital or consumable sale model, with recurring consumables as procedures grow.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
APT Medical product offering
Product offeringCore offering
APT Medical develops, manufactures, and sells cardiovascular interventional medical devices with two primary product lines: (1) cardiac electrophysiology products including 3D cardiac mapping systems, RF and pulsed field ablation (PFA) catheters, mapping catheters, multi-channel physiological recorders, and cardiac stimulators; and (2) vascular intervention products including guidewires, microcatheters, balloon catheters (PTCA, NC, scoring, anchoring), sheaths, thrombectomy catheters, and guide extension catheters for coronary, peripheral, and neurovascular interventions. The company also provides OEM/ODM catheter manufacturing services and physician training programs.
Product overview
APT Medical (深圳惠泰医疗器械股份有限公司, stock code 688617.SH) is a high-tech enterprise specializing in cardiac electrophysiology and interventional vascular medical devices. The product portfolio is organized into four main segments: (1) Electrophysiology Products — the core platform is the HT Viewer™ (HT-9000) 3D cardiac electrophysiology mapping system, the world's first 'three-in-one' magneto-electrical fusion platform integrating 3D mapping, 128-channel multi-channel recorder, and cardiac stimulator, paired with ablation catheters including AForcePlus™ magnetic-electrical positioning pressure-sensing PFA catheter and Pulstamper™ circular PFA catheter (pulsed field ablation), RF ablation catheters (magnetic positioning cold saline RF and可控 RF), and comprehensive mapping catheters (环形肺静脉, 星型, 环形, 十极, 二十极, 固定弯); (2) Coronary Pathway Products — diagnostic products including Blackeel™ hydrophilic-coated guide wires, Braidin™/Braidin™ II/Braidin™ Pro vascular sheaths, Angiopointer™/Hydropointer™ angiography catheters; therapeutic products including AnyreachC™/AnyreachP™/Anyreach C II™ guide wires, Bannerman™ and BingoReach™ CTO guide wires, CONQUEROR™ PTCA balloon family (PTCA, Ⅱ, NC, NC Spiker, NC Pro, Ridge, Epoch, Pod, Trap锚定), Tiburon™ balloon, DUALTRACK™ dual-lumen microcatheter, iPass Pro™/Instantpass™/Distail™ microcatheters, Expressman™/Expressman Ⅱ™ guide extension catheters, Sniffer™/Sniffer Ⅱ™ thrombectomy catheters, Dredger™ support catheter, and Lawnest™/vascular retrieval devices; (3) Peripheral Vascular Products — including Braidin™ TIPS instruments, Tresfort™ 18 peripheral balloon, HE Pearl™/DC Pearl™ PVA embolization microspheres,灌注导管; (4) OEM/ODM Services — custom manufacturing of 可调弯 catheters,管材, 鞘管, 导丝, 镍钛, and配件. The company also offers the HIERS™ multi-channel physiological recorder (integrated EP recorder, stimulator, and vital signs monitoring), PFG-micro1 PFA generator, RFG20A RF ablation generator, and IP-1 RF perfusion pump.
Differentiator
Problem solved
Functional benefit
Brands
- 埃普特医疗 (APT Medical Brand): Primary brand for coronary and peripheral interventional products including vascular sheaths, micro-catheters, guidewires, and balloons.
- 惠泰医疗
- Dragon Wind 微导管
- Enlarger 球囊扩张压力泵
- 墨工 可调弯输送鞘
Products and services
- HT Viewer™ Three-Dimensional Cardiac Electrophysiology Mapping System (HT-9000) World's first 'three-in-one' (三机一体) magnetic-electric fusion 3D platform integrating 3D mapping system, 128-channel multi-channel recorder, and cardiac stimulator into a single system. Provides real-time magnetic-electric positioning with sub-millimeter (<1mm) accuracy, digital filtering, intelligent mapping scoring, and full procedure recording. Targeted at electrophysiology labs performing arrhythmia ablation procedures.
- PFG-micro1 Cardiac Pulsed Field Ablation Generator PFA generator with intelligent real-time interaction with HT Viewer 3D mapping system. Supports linear and circular PFA catheters; single charge for multiple discharges; three ablation modes; pressure monitoring module. NMPA innovative product designation.
- AForcePlus™ Magnetic-Electrical Positioning Pressure-Monitoring Pulsed Field Ablation Catheter First NMPA-approved magnetic-electrical positioning pressure-sensing pulsed linear ablation catheter for atrial fibrillation treatment. Features real-time contact force gram and direction display, 1-2 electrode bipolar pulsed discharge with minimal patient pain and muscle tremor. Used by electrophysiologists during PFA procedures.
- Pulstamper™ Circular Pulsed Field Ablation Catheter First one-license dual-form magnetic-electric positioning PFA catheter with local impedance-based tissue contact indication. Multi-electrode circular/discrete ring design for efficient pulmonary vein isolation; three ablation modes; multi-morphology multi-specification options. Used by electrophysiologists for atrial fibrillation treatment.
- Magnetic Positioning Saline-Irrigated RF Ablation Catheter Magnetic positioning saline-irrigated RF ablation catheter with built-in magnetic sensor for real-time spatial positioning during RF ablation procedures. Segmented shaft design with hardness gradient; compatible with HT Viewer system and RF ablation generators. Used by electrophysiologists performing radiofrequency ablation of arrhythmias.
- ACEcho™ Disposable Intracardiac Ultrasound Diagnostic Catheter First NMPA-approved ICE catheter from APT Medical with magnetic sensor compatible with HT Viewer 3D mapping. 10F/90cm shaft; phased-array probe; 15-16cm penetration depth; 360° four-way steering; integrates ultrasound imaging with 3D electroanatomical mapping. Used in EP procedures for real-time intracardiac imaging.
- Magnetic Positioning Circular Mapping Catheter Magnetic positioning circular mapping catheter with magnetic sensor compatible with HT Viewer 3D mapping system for multi-electrode cardiac chamber mapping and pulmonary vein potential recording. Multiple ring diameters for matching different patient pulmonary vein sizes. Used by electrophysiologists for atrial fibrillation mapping.
- Magnetic Positioning Star-Shaped Mapping Catheter Magnetic positioning star-shaped mapping catheter with 5 soft 2.7F branches and 8cm² single-move coverage. Ultra-small 0.8mm electrodes for identifying abnormal potentials; available in 22-electrode and 32-electrode configurations; compatible with HT Viewer system. Used for high-density cardiac chamber mapping.
- Braidin Cross™ Atrial Septal Puncture System Atrial septal puncture system for establishing left atrial access during ablation procedures. Features braided sheath for superior torquability and kink resistance, PTFE inner wall, hydrophilic coating, and sharp needle with boss for safety. Used by electrophysiologists performing left atrial ablation.
- HIERS™ Multi-Channel Physiological Recorder High-integration physiological recorder combining multi-channel EP recorder, stimulator, and vital signs monitoring (SpO2, invasive/non-invasive blood pressure) in one device. Smallest footprint design for bedside installation; applicable across EP ablation, pacemaker, coronary and structural heart procedures.
- CONQUEROR™ Trap Anchoring Balloon Dilation Catheter China's first balloon anchoring catheter for guide catheter wire exchange. No guide wire lumen; metal push rod; 112cm effective length for deep intubation without extending out of guide catheter. Ultra-high pressure tolerance for reliable anchoring. Reduces vascular complications and shortens procedure time in PCI.
- CONQUEROR™ II PTCA Balloon Catheter PTCA balloon catheter with brand-new flexible balloon material, selective hydrophilic coating, tri-fold memory technology, and 1.0mm balloon size with 0.0158" profile. Used by interventional cardiologists for pre-dilation in percutaneous coronary intervention procedures.
- CONQUEROR™ NC Spiker Coronary Balloon Dilation Catheter New-generation non-compliant balloon with optimized tip design and new hydrophilic coating for improved trackability in tortuous vessels. Dual-layer balloon skin for superior compliance and high-pressure resistance. RBP 22atm. Used by interventional cardiologists for non-compliant post-dilation in PCI.
- CONQUEROR™ NC Pro Balloon Dilation Catheter Non-compliant balloon with unique spherical tip design converting stent strut contact surface to curved surface to prevent opposing contact. Dual-layer balloon tube for enhanced pressure tolerance; all sizes kissable in 6F guide catheter. Used by interventional cardiologists for stent deployment and post-dilation.
- Anyreach C II™ Work Guidewire Second-generation work guide wire with heterogeneous metal core wire seamless welding improving torque transmission efficiency. Enhanced distal silicone oil coating for safety and tactile feedback; upgraded welding process reducing 'wire detachment' risk. Used as primary workhorse guidewire in PCI.
- Bannerman™ Work Guidewire New-generation work guide wire with integrated stainless steel core and new safety mesh structure achieving balanced safety and manipulability. Multiple tip hardness and support configurations for flexible clinical application scenarios. Used by interventional cardiologists as a workhorse guidewire in PCI procedures.
- BingoReach™ CTO-Specific Guidewire CTO-specific guide wire with hydrophilic coating and polymer sleeve for superior lubricity. NiTi distal core with memory function; 5 tip hardness options (1.5/3/4.5/6/12g); pre-shaped tip design for precise lesion hardness sensing and steering. Used by interventional cardiologists for chronic total occlusion PCI.
- BLackeelPro™ Hydrophilic-Coated Diagnostic Guidewire Enhanced hydrophilic-coated diagnostic angiography guide wire with new patent A coating technology for durable lubrication. Hybrid wire design combining coil spring tip and hydrophilic-coated support segment; multiple tip shapes and sizes. Used for diagnostic angiography procedures.
- iPass Pro™ Microcatheter Full torque-control series microcatheter for CTO all scenarios. 1.9F/2.1F/2.6F sizes; 135/150cm working lengths; side hole option on 135cm; stainless steel braid and multi-coil composite reinforcement; patent octagonal strain relief sleeve. Used by interventional cardiologists for CTO and complex PCI.
- Tresfort™ 18 Peripheral Balloon Dilation Catheter Peripheral balloon dilation catheter with 0.020" bidirectional laser-shaped tip for excellent lesion entry. Tapered balloon conforming to peripheral vessel anatomy; tri-fold balloon folding; unique push rod inner-outer layer spot welding. Used by interventional radiologists and vascular surgeons for peripheral artery disease.
- HE Pearl™ PVA Embolization Microsphere PVA embolization microsphere with precise particle size and excellent rebound resilience. Spherical smooth design with superior suspended fluidity and lumen passability; reduces intraoperative tube blockage risk. Used by interventional radiologists for embolization procedures including TACE for liver cancer.
- DC Pearl™ PVA Embolization Microsphere Drug-eluting PVA embolization microsphere with 96%+ drug loading in 5 minutes and sustained drug release. Stable particle size; high compression ratio; innovative three-specification combo packaging for sequential embolization. Used for TACE in hepatocellular carcinoma and other embolization procedures.
- OEM/ODM Contract Manufacturing Services for Interventional Medical Devices OEM and ODM services for catheters, tubing, sheaths, guidewires, nitinol components, and accessories for other medical device companies. Categories on the company website include adjustable bend, tubing, sheath, guidewire, nitinol, and accessories. Targeted at medical device manufacturers needing outsourced catheter/interventional component manufacturing.
Quantifiable outcome
- Positioning accuracy <1mm for HT Viewer 3D mapping system
- +4 more outcomes
Companies that use APT Medical
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
APT Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability3 records
Feature6 records
APT Medical partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered regional and core.
- KLNregionalKLN has been named as the full-line distributor for APT Medical's coronary intervention products in Hong Kong. This strategic distribution partnership enables APT Medical to reach hospitals and physicians in Hong Kong through KLN's established local commercial network.
- Mindray MedicalcoreMindray Medical disclosed strategic acquisition of APT Medical as part of its three-pillar growth strategy presented at 2026 J.P. Morgan Healthcare Conference. The acquisition is intended to expand Mindray's presence in cardiovascular intervention and minimally invasive surgery markets. Mindray generates 50% of revenue internationally and 40% from recurring business.
Scale indicators7 records
Recent moves8 records
Expansion highlights6 records
APT Medical competitors and assessment
Company assessmentBroad incumbents
- Lepu Medical (乐普医疗): Lepu Medical is a leading Chinese cardiovascular medical device company with broad portfolios in coronary stents, balloon catheters, and interventional accessories. It is a domestic incumbent comparable to APT in vascular intervention and a key reference for Chinese cardiovascular device competitive dynamics.
- Medtronic: Medtronic is a global leader in cardiac EP through its CardioInsight mapping and PulseSelect/Affera PFA systems, and competes across coronary intervention with its Resolute drug-eluting stent franchise. Its broad global reach and clinical evidence depth make it a primary incumbent for APT in international expansion.
- Boston Scientific: Boston Scientific competes in cardiac EP through its RHYTHMIA HDx mapping system and offers the POLARx and Farapulse PFA systems globally. It is a key global incumbent across both EP ablation and coronary/peripheral vascular intervention that APT Medical positions against.
- Johnson & Johnson (Biosense Webster): Biosense Webster is the global market leader in cardiac electrophysiology, offering the CARTO 3D mapping system and a broad ablation catheter portfolio. It is APT Medical's primary global incumbent competitor and the technology benchmark APT's HT Viewer and PFA programs aim to displace.
- Penumbra: Penumbra is a global leader in thrombectomy and peripheral vascular intervention with overlapping products in aspiration catheters and embolization. Its presence in vascular intervention and growing peripheral portfolio makes it a comparable peer for APT's non-EP interventional product lines.
- Abbott: Abbott is a global leader in cardiac EP through its EnSite mapping system and Advisor ablation catheter portfolio (including TactiCath and recent PFA programs). It competes with APT across both EP and vascular intervention product lines globally and is a primary substitute at large hospitals.
Emerging players
- Pulse Biosciences: Pulse Biosciences is a pure-play PFA technology company developing nano-PFA ablation for cardiac arrhythmias. As a focused emerging player in the same modality APT Medical is commercializing, it represents both a competitive threat and an indicator of the technology's commercial potential.
- Stereotaxis: Stereotaxis develops robotic magnetic navigation systems for cardiac EP ablation procedures, providing an alternative mapping and catheter navigation approach to APT's magneto-electric fusion HT Viewer platform. It is a niche emerging player with overlapping clinical use cases in complex arrhythmia ablation.
Direct peers
- Shanghai MicroPort EP Medtech (微创电生理): Shanghai MicroPort EP Medtech is the most direct competitor to APT Medical, offering a competing portfolio of cardiac electrophysiology devices including 3D mapping systems, RF and cryoablation catheters, and diagnostic catheters in the China market. Both companies compete head-to-head for the same hospital accounts under Chinese domestic substitution tailwinds.
- Jiangsu Micro-Tech (JMT/江苏微创医疗): Jiangsu Micro-Tech is another Chinese EP and vascular intervention medical device company with overlapping product lines including ablation catheters, mapping systems, and guidewires. It competes directly with APT Medical in domestic EP hospital sales and shares the import-substitution narrative.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
APT Medical social profiles
Digital presenceAPT Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
APT Medical leadership team
Management profileNumber of profiles
Profiles7 records
APT Medical subsidiaries and ownership
Company hierarchySubsidiaries2 records
APT Medical funding detail
Funding detailFunding overview
Funding rounds5 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
APT Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about APT Medical
What does APT Medical do?
APT Medical develops, manufactures, and sells cardiovascular interventional medical devices with two primary product lines: (1) cardiac electrophysiology products including 3D cardiac mapping systems, RF and pulsed field ablation (PFA) catheters, mapping catheters, multi-channel physiological recorders, and cardiac stimulators; and (2) vascular intervention products including guidewires, microcatheters, balloon catheters (PTCA, NC, scoring, anchoring), sheaths, thrombectomy catheters, and guide extension catheters for coronary, peripheral, and neurovascular interventions. The company also provides OEM/ODM catheter manufacturing services and physician training programs.
Is APT Medical a public or private company?
APT Medical is a public company. It is classified as corporate owned and is currently operating.
When was APT Medical founded?
APT Medical was founded in 2002. It employs 1,001 to 5,000 people.
Where is APT Medical based?
APT Medical is headquartered in Shenzhen, China, in the Asia region.
How does APT Medical make money?
One revenue line is on record: medical Device and Consumable Sales.
Who are APT Medical's main competitors?
Broad incumbents on record are Lepu Medical (乐普医疗), Medtronic, Boston Scientific, Johnson & Johnson (Biosense Webster), Penumbra and Abbott. Emerging players are Pulse Biosciences and Stereotaxis. Direct peers are Shanghai MicroPort EP Medtech (微创电生理) and Jiangsu Micro-Tech (JMT/江苏微创医疗).
Does APT Medical have an API?
No public API is recorded for APT Medical.
What industry is APT Medical in?
APT Medical's product category is Cardiovascular Interventional Medical Devices. Its primary akta.pro industry code is HLAHAFAD, Electrophysiology Mapping & Ablation Systems, with a secondary code of HLAKABAB, Interventional Cardiology (PCI/Structural Heart). Its NAICS code is 334510 and its SIC code is 3845.